Lifevantage Corporation (NASDAQ:LFVN - Get Free Report) shares crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $16.18 and traded as low as $12.55. Lifevantage shares last traded at $12.76, with a volume of 49,131 shares trading hands.
Lifevantage Trading Down 1.1%
The company has a 50 day moving average price of $12.69 and a 200 day moving average price of $16.11. The company has a market capitalization of $157.30 million, a P/E ratio of 18.07 and a beta of 0.43.
Lifevantage (NASDAQ:LFVN - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.10. The firm had revenue of $58.44 million during the quarter, compared to analysts' expectations of $60.99 million. Lifevantage had a net margin of 4.12% and a return on equity of 34.67%.
Lifevantage Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 30th were given a dividend of $0.045 per share. The ex-dividend date was Friday, May 30th. This is an increase from Lifevantage's previous quarterly dividend of $0.04. This represents a $0.18 annualized dividend and a yield of 1.44%. Lifevantage's dividend payout ratio (DPR) is 26.09%.
Institutional Investors Weigh In On Lifevantage
A number of institutional investors have recently made changes to their positions in the company. Capital Management Corp VA lifted its holdings in Lifevantage by 137.2% during the 1st quarter. Capital Management Corp VA now owns 715,503 shares of the company's stock worth $10,432,000 after purchasing an additional 413,918 shares during the last quarter. Driehaus Capital Management LLC bought a new stake in shares of Lifevantage in the first quarter valued at about $6,701,000. Acadian Asset Management LLC boosted its position in shares of Lifevantage by 47.3% in the first quarter. Acadian Asset Management LLC now owns 291,700 shares of the company's stock valued at $4,248,000 after acquiring an additional 93,661 shares during the period. LPL Financial LLC grew its stake in shares of Lifevantage by 301.0% in the fourth quarter. LPL Financial LLC now owns 211,039 shares of the company's stock valued at $3,700,000 after acquiring an additional 158,405 shares in the last quarter. Finally, Susquehanna International Group LLP increased its position in Lifevantage by 83.5% during the fourth quarter. Susquehanna International Group LLP now owns 128,082 shares of the company's stock worth $2,245,000 after acquiring an additional 58,279 shares during the period. Institutional investors own 35.32% of the company's stock.
Lifevantage Company Profile
(
Get Free Report)
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
See Also
Before you consider Lifevantage, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lifevantage wasn't on the list.
While Lifevantage currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.